More discussion on journal impact factor
-
Eleftherios P. Diamandis
In 2009, Clinical Chemistry and Laboratory Medicine published two ‘opinion’ papers, one by myself [1] and another one by Favaloro [2], debating the usefulness and longevity of the journal impact factor. At that time, I predicted that journal impact factor will fade away soon, while Dr. Favaloro expressed a different, opposing opinion.
Recently, during the 2012 American Society for Cell Biology meeting, the usefulness of the journal impact factor has been debated [3]. These deliberations led to the preparation of a document known as The San Francisco Declaration of Research Assessment (DORA), which has been sponsored/signed by more than 150 leading scientists and 75 scientific organizations. DORA stipulates that the journal impact factor must not be used as a surrogate measure of the quality of individual research articles, to assess an individual scientist’s contributions, or used in hiring, promotion and funding decisions. The declaration further recommends alternative metrics for evaluating researchers, including citation counts of individual articles. Essentially, these recommendations endorse the central message of my previous editorial [1], which states that the impact of an individual paper is not necessarily related to the impact factor of the journal that published it.
I believe that the readers of Clinical Chemistry and Laboratory Medicine who have read the previous commentaries on journal impact factor [1, 2], should be interested to look at these latest recommendations (www.ascb.org/SFdeclaration.html).
Conflict of interest statement
Authors’ conflict of interest disclosure: The authors stated that there are no conflicts of interest regarding the publication of this article.
Research funding: None declared.
Employment or leadership: None declared.
References
1. Diamandis EP. Journal impact factor: it will go away soon. Clin Chem Lab Med 2009;47:1317–8.10.1515/CCLM.2009.327Suche in Google Scholar PubMed
2. Favaloro EJ. The journal impact factor: don’t expect its immediate demise any time soon. Clin Chem Lab Med 2009;47:1319–24.http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=000272257700018&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=b7bc2757938ac7a7a821505f8243d9f3Suche in Google Scholar
3. Alberts B. Impact factor distortions. Science 2013;340:787.10.1126/science.1240319Suche in Google Scholar PubMed
©2013 by Walter de Gruyter Berlin Boston
Artikel in diesem Heft
- Letters to the Editor
- The addition of MESNA in vitro prolongs prothrombin time similar to N-acetyl cysteine
- Detection of unknown β-thalassemia cases from atypical HbA1c chromatograms
- Analytical study of a new turbidimetric assay for urinary neutrophil gelatinase-associated lipocalin (NGAL) determination
- The rare bipolar-contracted red cell significance and correlation with red cell volume
- Howell-Jolly body interference in reticulocyte counts
- PBMC expressed adiponectin mRNA is predictive of survival in patients with gastric cancer
- Comparison study of two commercially available methods for the determination of infliximab, adalimumab, etanercept and anti-drug antibody levels
- Development and validation of a rapid and reliable high-performance liquid chromatography method for methadone quantification in human plasma and saliva
- Reply to Ruiz-Argüello et al.: Comparison study of two commercially available methods for the determination of infliximab, adalimumab, etanercept and anti-drug antibody levels
- Still more discussion on the journal impact factor
- The order of draw, myth or science
- Masthead
- Masthead
- Editorial
- Multidisciplinarity and interdisciplinarity at work: the prenatal diagnosis
- Research Articles
- Prenatal diagnosis of inherited diseases: 20 years’ experience of an Italian Regional Reference Centre
- Prenatal diagnosis of haemoglobinopathies: our experience of 523 cases
- Prenatal diagnosis of cystic fibrosis: an experience of 181 cases
- Prenatal diagnosis of haemophilia: our experience of 44 cases
- Prenatal molecular diagnosis of inherited neuromuscular diseases: Duchenne/Becker muscular dystrophy, myotonic dystrophy type 1 and spinal muscular atrophy
- Editorials
- Journal impact factor: the debate continues
- Estimation of uncertainty in measurements in the clinical laboratory
- Review
- Searching for genes involved in hypertension development in special populations: children and pre-eclamptic women. Where are we standing now?
- Opinion Paper
- More discussion on journal impact factor
- General Clinical Chemistry and Laboratory Medicine
- Category-specific uncertainty modeling in clinical laboratory measurement processes
- The order of draw: myth or science?
- Planned variation in preanalytical conditions to evaluate biospecimen stability in the National Children’s Study (NCS)
- Longitudinal evaluation of thyroid autoimmunity and function in pregnant Korean women
- Evaluation of the N Latex free light chain assay in the diagnosis and monitoring of AL amyloidosis
- Identification of an important potential confound in CSF AD studies: aliquot volume
- Cancer Diagnostics
- Double heterozygosity in the BRCA1 and BRCA2 genes in Italian family
- Quantification of EGFR autoantibodies in the amplification phenomenon of HER2 in breast cancer
- Diabetes
- SAA1 genetic polymorphisms are associated with plasma glucose concentration in non-diabetic subjects
- Acknowledgment
- Acknowledgment
Artikel in diesem Heft
- Letters to the Editor
- The addition of MESNA in vitro prolongs prothrombin time similar to N-acetyl cysteine
- Detection of unknown β-thalassemia cases from atypical HbA1c chromatograms
- Analytical study of a new turbidimetric assay for urinary neutrophil gelatinase-associated lipocalin (NGAL) determination
- The rare bipolar-contracted red cell significance and correlation with red cell volume
- Howell-Jolly body interference in reticulocyte counts
- PBMC expressed adiponectin mRNA is predictive of survival in patients with gastric cancer
- Comparison study of two commercially available methods for the determination of infliximab, adalimumab, etanercept and anti-drug antibody levels
- Development and validation of a rapid and reliable high-performance liquid chromatography method for methadone quantification in human plasma and saliva
- Reply to Ruiz-Argüello et al.: Comparison study of two commercially available methods for the determination of infliximab, adalimumab, etanercept and anti-drug antibody levels
- Still more discussion on the journal impact factor
- The order of draw, myth or science
- Masthead
- Masthead
- Editorial
- Multidisciplinarity and interdisciplinarity at work: the prenatal diagnosis
- Research Articles
- Prenatal diagnosis of inherited diseases: 20 years’ experience of an Italian Regional Reference Centre
- Prenatal diagnosis of haemoglobinopathies: our experience of 523 cases
- Prenatal diagnosis of cystic fibrosis: an experience of 181 cases
- Prenatal diagnosis of haemophilia: our experience of 44 cases
- Prenatal molecular diagnosis of inherited neuromuscular diseases: Duchenne/Becker muscular dystrophy, myotonic dystrophy type 1 and spinal muscular atrophy
- Editorials
- Journal impact factor: the debate continues
- Estimation of uncertainty in measurements in the clinical laboratory
- Review
- Searching for genes involved in hypertension development in special populations: children and pre-eclamptic women. Where are we standing now?
- Opinion Paper
- More discussion on journal impact factor
- General Clinical Chemistry and Laboratory Medicine
- Category-specific uncertainty modeling in clinical laboratory measurement processes
- The order of draw: myth or science?
- Planned variation in preanalytical conditions to evaluate biospecimen stability in the National Children’s Study (NCS)
- Longitudinal evaluation of thyroid autoimmunity and function in pregnant Korean women
- Evaluation of the N Latex free light chain assay in the diagnosis and monitoring of AL amyloidosis
- Identification of an important potential confound in CSF AD studies: aliquot volume
- Cancer Diagnostics
- Double heterozygosity in the BRCA1 and BRCA2 genes in Italian family
- Quantification of EGFR autoantibodies in the amplification phenomenon of HER2 in breast cancer
- Diabetes
- SAA1 genetic polymorphisms are associated with plasma glucose concentration in non-diabetic subjects
- Acknowledgment
- Acknowledgment
